
Specialist, Cell Therapy Patient Operations
Posted Oct 21

Posted Oct 21
This is a fully remote position, open to applicants in United States.
• Collaborate with clinical site study coordinators, apheresis centers, CDMOs, couriers, and internal stakeholders to uphold patient treatment schedules.
• Manage daily scheduling and cell logistics operations from enrollment through to drug product delivery.
• Relay updates regarding scheduling, manufacturing milestones, product availability, and logistics requirements.
• Oversee patient scheduling and logistics tasks.
• Recognize, communicate, and escalate any scheduling conflicts, manufacturing delays, logistics risks, chain of identity issues, and clinical site support requirements to the Director of Patient Operations.
• Ensure precise scheduling and logistics records and trackers are maintained in accordance with Patient Operations procedures.
• One to two years of experience in the biotech or cell therapy sector.
• Demonstrated experience in scheduling, planning, and logistics coordination.
• Strong understanding of GMP and GTP standards.
• Excellent analytical and problem-solving capabilities.
• Outstanding attention to detail and a firm commitment to achieving right-first-time execution.
• Proven ability to forge and sustain strong cross-functional and external relationships.
• Self-motivated with adaptability, creativity, and the ability to excel in a fast-paced startup environment.
• Preferred: Experience in supporting autologous cell therapy clinical trials, managing chain of identity and chain of custody processes, coordinating temperature-sensitive shipments, and utilizing scheduling or case management systems.
• Must be available to work afternoon hours in Pacific Standard Time (PST).
• Participation in on-call rotation.
• Opportunity to occasionally work outside regular business hours to assist with time-sensitive patient and product activities.
Intellect
Sword Health
AXIS Teletherapy
AXIS Teletherapy
Get handpicked remote jobs straight to your inbox weekly.